CVM: Start Your Engines - FDA Green Lights Confirmatory Registration Study
CEL-SCI is developing two platforms: Multikine and LEAPS. Multikine has completed a Phase 3 trial for head and neck cancer while LEAPS is...
CVM: Confirmatory Study Clarity
CEL-SCI is developing two platforms: Multikine and LEAPS. Multikine has completed a Phase 3 trial for head and neck cancer while LEAPS is...
No more insights